Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
Clinical trial NCT04046939 · COMPLETED
Trial details
- NCT number
- NCT04046939
- Sponsor
- Knopp Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2020-12-03
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.